Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes

Glycaemic variability in diabetes: clinical and therapeutic implications

(2018) Antonio Ceriello et al.   Lancet Diabetes & Endocrinology

Metrics for glycaemic control — from HbA1c to continuous glucose monitoring

(2017) Boris P. Kovatchev   Nature Reviews Endocrinology

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM –2016 EXECUTIVE SUMMARY

(2016) Alan J. Garber et al.   Endocrine Practice

The heterogeneity statistic I2 can be biased in small meta-analyses

(2015) Paul T von Hippel   BMC Medical Research Methodology

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Predictive and Explanatory Factors of Change in HbA1cin a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs

(2014) Philip D. Home et al.   DIABETES CARE

Comparison of Insulin Aspart vs. Regular Human Insulin with or without Insulin Detemir Concerning Adipozytokines and Metabolic Effects in Patients with Type 2 Diabetes Mellitus

(2013) B. Herrmann et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences

(2012) P. D. Home   DIABETES OBESITY & METABOLISM

Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: Results from the A1chieve study

(2012) Nabil K. El Naggar et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries

(2011) Andreas Liebl et al.   CURRENT MEDICAL RESEARCH AND OPINION

Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetes

(2011) H Sourij et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Relation of fasting and postprandial and plasma glucose with hemoglobinA1c in diabetics

(2010) Shahram Haddadinezhad et al.   International Journal of Diabetes in Developing Countries

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

(2009) A. Pfützner et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Optimized Postprandial Glucose Control is Associated with Improved Cardiac/Vascular Function – Comparison of Three Insulin Regimens in Well-controlled Type 2 Diabetes

(2009) H. von Bibra et al.   HORMONE AND METABOLIC RESEARCH

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

(2009) S. Shah et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine

(2009) P. Brunetti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Glycemic Variability: Should we and can we prevent it?

(2008) L. Monnier et al.   DIABETES CARE